Risk of Bullous Pemphigoid with Type 2 Diabetes Drugs
August 12, 2018 – Findings from a retrospective case-control study were published online August 8, 2018, in JAMA Dermatology indicate that the use of certain dipeptidyl peptidase 4 (DPP-4) inhibitor drugs are associated with a small but significantly elevated risk for developing bullous …
Risk of Bullous Pemphigoid with Type 2 Diabetes Drugs Read more »